Efficacy, Safety, and Drug Survival During the First Year of Biologic Therapy for Psoriasis in Elderly Versus Younger Patients
The efficacy of biological treatment was comparable between older and younger patients. Despite older people having more comorbidities, SAEs did not increase in this age group. Nonetheless, the survival rate of older patients was notably lower during the treatment period, especially when adalimumab was administered.
Authors
- M Salavec (ORCID: https://orcid.org/0000-0002-2059-1683)
- Simona Vachatova (ORCID: https://orcid.org/0000-0002-4983-9152)
- M Tichý (ORCID: https://orcid.org/0000-0002-4925-2634)
- Martina Kojanová (ORCID: https://orcid.org/0000-0001-9890-9965)
- Alena Machovcová (ORCID: https://orcid.org/0000-0003-0550-1253)
- Miroslav Nečas
- Martin Cetkovsky
- Jan Hugo (ORCID: https://orcid.org/0000-0002-4341-3812)
- Simona Tivadar
- Filip Rob (ORCID: https://orcid.org/0000-0001-5257-205X)
- Natalie Kunesova
- Tereza Sobotkova
- Pavlina Prikrylova
- Zdenka Kysilka
Institutions
- Charles University (CZ)
- Masaryk University (CZ)
- University Hospital in Motol (CZ)
- University Hospital Olomouc (CZ)
- University Hospital Hradec Králové (CZ)
- University Hospital Kralovske Vinohrady (CZ)
- Palacký University Olomouc (CZ)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1111/ijd.17814
- Citations
- 3
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 2.39
Funders
- Ministerstvo Zdravotnictví Ceské Republiky